Janssen Rebuffs Samsung's Stelara Suit, Faces Fresh Claim
Janssen Biotech Inc. is pushing back on claims from Samsung Bioepis U.K. Ltd. that a patent protecting its blockbuster immunosuppressive Stelara should be nixed, shortly after being hit with yet another...To view the full article, register now.
Already a subscriber? Click here to view full article